Literature DB >> 11578545

[Acute bronchiolitis: fundamentals of a rational protocol].

D González Caballero1, E González Pérez-Yarza.   

Abstract

Bronchiolitis is the most frequent respiratory tract disease in the first 2 years of life. It occurs in epidemics in winter and spring. Etiology is viral and the most frequent causative agent is respiratory syncytial virus. In most patients the disease is benign and self-limiting and only occasionally requires hospitalization. In daily clinical practice, one of the problems most frequently faced by the pediatrician is the lack of agreement on the correct pharmacological treatment of bronchiolitis, as well as the absence of simple, or standardized, clinical scores with which to diagnose severity. The present study provides a review of the medical literature on the most commonly used clinical scores and the therapeutic efficacy of the different drugs employed. A protocol for the practical management of bronchiolitis is provided. The use of inhaled adrenaline in the treatment of moderate-to-severe bronchiolitis in hospitalized infants, as well as oxygen and fluid therapy as support measures, are recommended.

Entities:  

Mesh:

Year:  2001        PMID: 11578545

Source DB:  PubMed          Journal:  An Esp Pediatr        ISSN: 0302-4342


  7 in total

Review 1.  Effects of nebulized epinephrine in association with hypertonic saline for infants with acute bronchiolitis: A systematic review and meta-analysis.

Authors:  Renan A Pereira; Versiéri Oliveira de Almeida; Mariana Zambrano; Linjie Zhang; Sérgio L Amantéa
Journal:  Health Sci Rep       Date:  2022-04-18

Review 2.  Hypertonic Saline for the Treatment of Bronchiolitis in Infants and Young Children: A Critical Review of the Literature.

Authors:  Jeffrey Baron; Gladys El-Chaar
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

3.  Development and Validation of a New Clinical Scale for Infants with Acute Respiratory Infection: The ReSVinet Scale.

Authors:  Antonio José Justicia-Grande; Jacobo Pardo-Seco; Miriam Cebey-López; Lucía Vilanova-Trillo; Alberto Gómez-Carballa; Irene Rivero-Calle; María Puente-Puig; Carmen Curros-Novo; José Gómez-Rial; Antonio Salas; José María Martinón-Sánchez; Lorenzo Redondo-Collazo; Carmen Rodríguez-Tenreiro; Federico Martinón-Torres
Journal:  PLoS One       Date:  2016-06-21       Impact factor: 3.240

4.  Prospective Multicentre Study on the Epidemiology and Current Therapeutic Management of Severe Bronchiolitis in Spain.

Authors:  Jose C Flores-González; Juan Mayordomo-Colunga; Iolanda Jordan; Alicia Miras-Veiga; Cristina Montero-Valladares; Marta Olmedilla-Jodar; Andrés J Alcaraz-Romero; Miren Eizmendi-Bereciartua; Francisco Fernández-Carrión; Carmen Santiago-Gutierrez; Esther Aleo-Luján; Sonia Pérez-Quesada; Cristina Yun-Castilla; Carmen Martín; Álvaro Navarro-Mingorance; Concha Goñi-Orayen
Journal:  Biomed Res Int       Date:  2017-03-22       Impact factor: 3.411

Review 5.  Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old.

Authors:  Marta Roqué i Figuls; Maria Giné-Garriga; Claudia Granados Rugeles; Carla Perrotta; Jordi Vilaró
Journal:  Cochrane Database Syst Rev       Date:  2016-02-01

6.  Epinephrine Improves the Efficacy of Nebulized Hypertonic Saline in Moderate Bronchiolitis: A Randomised Clinical Trial.

Authors:  J Carlos Flores-González; Miguel A Matamala-Morillo; Patricia Rodríguez-Campoy; Juan J Pérez-Guerrero; Belén Serrano-Moyano; Paloma Comino-Vazquez; Encarnación Palma-Zambrano; Rocio Bulo-Concellón; Vanessa Santos-Sánchez; Alfonso M Lechuga-Sancho
Journal:  PLoS One       Date:  2015-11-17       Impact factor: 3.240

7.  Nasal and Fecal Microbiota and Immunoprofiling of Infants With and Without RSV Bronchiolitis.

Authors:  Claudio Alba; Marina Aparicio; Felipe González-Martínez; María Isabel González-Sánchez; Jimena Pérez-Moreno; Blanca Toledo Del Castillo; Juan Miguel Rodríguez; Rosa Rodríguez-Fernández; Leonides Fernández
Journal:  Front Microbiol       Date:  2021-06-01       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.